“Pharmacists are essential members of an interprofessional oncology treatment team. They are a critical resource to patients undergoing cancer treatment." - David Heckard, president of PTCE.
Plainsboro, N.J. (PRWEB) August 16, 2016
Physicians’ Education Resource (PER®) announces a partnership with Pharmacy Times Continuing Education (PTCE™) to accredit the 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® for pharmacists. Offering pharmacists credits at this flagship continuing education symposium allows PER to increase collaboration with pharmacists by providing education that addresses their specific clinical needs.
“PER is dedicated to advancing cancer care through professional education, and we are excited that our partnership with PTCE will enable the 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow to continue its legacy of providing continuing education credits to pharmacists,” said PER’s President, Phil Talamo. Accredited/certified for physicians and nurses by leading oncology and hematology CME/CE provider, PER, this year’s national meeting will take place Nov. 9-11, at the Marriott Marquis in New York City.
“Pharmacists are essential members of an interprofessional oncology treatment team,” David Heckard, president of PTCE, noted. “They are a critical resource to patients undergoing cancer treatment. Pharmacists are on the front lines of patient care, providing side effect management, patient education, and advocacy for patients undergoing complicated, sometimes long-term treatments. It is critically important for them to keep up with the complexities of evolving cancer treatments.”
Since 1995, PER has been the educational resource of choice for live and online activities focusing on oncology and hematology. PER provides high-quality, evidence-based activities featuring leading national and international faculty with a focus on practice-changing advances and standards of care in treatment and disease management. Activities also include topics on emerging strategies currently under investigation, supportive care, diagnosis and staging, prevention, screening and early detection, and practice management.
With the rapid advances occurring in the field of oncology, understanding how to use molecular data to diagnose and stage patients, selecting the most appropriate candidates for novel therapeutic agents, individualizing treatment based on tumor type, and referring patients to clinical trials will continue to ensure the highest level of patient care is provided.
PER serves the oncology health care community, including physicians, fellows, advanced practice nurses, nurses, physician assistants, pharmacists, and researchers. PER is part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Activities produced by PTCE include live meetings and Webinars as well as home study formats (print- and internet-based). Using their long-standing relationship with the journal, Pharmacy Times, PTCE enjoys a wide distribution of our continuing pharmacy education activities to more than 250,000 practicing pharmacists. PTCE is part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.pharmacytimes.org and http://www.mjhassoc.com.